Integrative Analysis of Transcriptional Regulation of the ATG4D, an Autophagy-Related Gene, Using JASPAR and STRING databases.
DOI:
https://doi.org/10.31185/wjps.414Keywords:
Autophagy, ATG4D, JASPAR, STRING, TF, TFBSAbstract
Autophagy is a catabolic cellular process that is conserved and plays an important role in sustaining cellular stability, adjusting to malnourishment, and responding to cellular stress. ATG4D is a gene that involves the formation of the autophagosome and is considered a key player in autophagy. Inclusive knowledge of how the ATG4D gene is regulated may provide insights into the gene's role in different cellular aspects. In this research, bioinformatics tools were utilized, specifically the JASPAR database, to predict the transcription factor binding sites (TFBS) and transcription factors (TFs) binding to the ATG4D promoter region. Multiple TFs were identified, and among these identified TFs, we focused on eight that were well-known for their established roles in regulating autophagy, responding to cellular stress, and promoting transcriptional regulation of ATG4D. These TFs include FOXO3, TFEB, TP53, SP1, STAT3, NF-κB, E2F1, and CREB1. To discover the functional interactions of these TFs, the STRING database was utilized to conduct protein-protein interaction analysis and functional enrichment. This analysis helped us to better comprehend the complicated regulatory network linked to autophagy and the precise role of ATG4D. Functional enrichment analysis revealed significant gene ontology terms and pathways linked with autophagy, cellular stress response, apoptosis, and transcriptional regulation. These findings indicate that the regulation of ATG4D gene expression is shaped by a complicated network of transcription factors that play significant roles in autophagy and sustaining cellular balance. Using a combination of bioinformatics tools such as JASPAR and STRING gave a thorough insight into the regulatory atmosphere of ATG4D, providing opportunities for treating diseases associated with autophagy dysregulation.
References
C. Settembre and A. Ballabio, “Lysosome: Regulator of lipid degradation pathways,” Trends in Cell Biology, vol. 24, no. 12. Elsevier Ltd, pp. 743–750, Dec. 01, 2014. doi: 10.1016/j.tcb.2014.06.006.
L. Galluzzi et al., “Molecular definitions of autophagy and related processes,” EMBO J, vol. 36, no. 13, pp. 1811–1836, Jul. 2017, doi: 10.15252/embj.201796697.
H. Nakatogawa, “Mechanisms governing autophagosome biogenesis,” Nature Reviews Molecular Cell Biology, vol. 21, no. 8. Nature Research, pp. 439–458, Aug. 01, 2020. doi: 10.1038/s41580-020-0241-0.
H. Park, J. H. Kang, and S. Lee, “Autophagy in neurodegenerative diseases: A hunter for aggregates,” International Journal of Molecular Sciences, vol. 21, no. 9. MDPI AG, May 01, 2020. doi: 10.3390/ijms21093369.
Z. Wang and C. Li, “Xenophagy in innate immunity: A battle between host and pathogen,” Developmental and Comparative Immunology, vol. 109. Elsevier Ltd, Aug. 01, 2020. doi: 10.1016/j.dci.2020.103693.
J. Debnath, N. Gammoh, and K. M. Ryan, “Autophagy and autophagy-related pathways in cancer,” Nature Reviews Molecular Cell Biology, vol. 24, no. 8. Nature Research, pp. 560–575, Aug. 01, 2023. doi: 10.1038/s41580-023-00585-z.
M. Bordi, R. De Cegli, B. Testa, R. A. Nixon, A. Ballabio, and F. Cecconi, “A gene toolbox for monitoring autophagy transcription,” Cell Death Dis, vol. 12, no. 11, Nov. 2021, doi: 10.1038/s41419-021-04121-9.
M. Morimoto et al., “Bi-allelic ATG4D variants are associated with a neurodevelopmental disorder characterized by speech and motor impairment,” NPJ Genom Med, vol. 8, no. 1, Dec. 2023, doi: 10.1038/s41525-022-00343-8.
V. M. S. Betin and J. D. Lane, “Atg4D at the interface between autophagy and apoptosis,” Autophagy, vol. 5, no. 7. Taylor and Francis Inc., pp. 1057–1059, Oct. 01, 2009. doi: 10.4161/auto.5.7.9684.
I. Tamargo-Gómez et al., “ATG4D is the main ATG8 delipidating enzyme in mammalian cells and protects against cerebellar neurodegeneration,” Cell Death Differ, vol. 28, no. 9, pp. 2651–2672, Sep. 2021, doi: 10.1038/s41418-021-00776-1.
V. M. S. Betin, T. D. B. MacVicar, S. F. Parsons, D. J. Anstee, and J. D. Lane, “A cryptic mitochondrial targeting motif in Atg4D links caspase cleavage with mitochondrial import and oxidative stress,” Autophagy, vol. 8, no. 4, pp. 664–676, 2012, doi: 10.4161/auto.19227.
I. Tamargo-Gómez, G. G. Martínez-García, M. F. Suárez, A. F. Fernández, and G. Mariño, “ATG4D role in mAtg8s delipidation and neuroprotection,” Autophagy, vol. 17, no. 6, pp. 1558–1560, 2021, doi: 10.1080/15548627.2021.1922979.
I. Tamargo-Gómez et al., “ATG4D is the main ATG8 delipidating enzyme in mammalian cells and protects against cerebellar neurodegeneration,” Cell Death Differ, vol. 28, no. 9, pp. 2651–2672, Sep. 2021, doi: 10.1038/s41418-021-00776-1.
J. L. Nieto-Torres, S. Zaretski, T. Liu, P. D. Adams, and M. Hansen, “Post-translational modifications of ATG8 proteins – an emerging mechanism of autophagy control,” Journal of Cell Science, vol. 136, no. 16. Company of Biologists Ltd, Aug. 01, 2023. doi: 10.1242/jcs.259725.
J. Gil et al., “The Influence of Tumor Microenvironment on ATG4D Gene Expression in Colorectal Cancer Patients,” Medical Oncology, vol. 35, no. 12, Dec. 2018, doi: 10.1007/s12032-018-1220-6.
D. Ebrahimi-Fakhari, L. Wahlster, G. F. Hoffmann, and S. Kölker, “Emerging role of autophagy in pediatric neurodegenerative and neurometabolic diseases,” Pediatric Research, vol. 75, no. 1–2. Nature Publishing Group, pp. 217–226, 2014. doi: 10.1038/pr.2013.185.
E. Portilla-Fernandez et al., “Dissecting the association of autophagy-related genes with cardiovascular diseases and intermediate vascular traits: A population-based approach,” PLoS One, vol. 14, no. 3, Mar. 2019, doi: 10.1371/journal.pone.0214137.
S. A. Lambert et al., “The Human Transcription Factors,” Cell, vol. 172, no. 4. Cell Press, pp. 650–665, Feb. 08, 2018. doi: 10.1016/j.cell.2018.01.029.
J. A. Castro-Mondragon et al., “JASPAR 2022: The 9th release of the open-access database of transcription factor binding profiles,” Nucleic Acids Res, vol. 50, no. D1, pp. D165–D173, Jan. 2022, doi: 10.1093/nar/gkab1113.
D. Szklarczyk et al., “The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest,” Nucleic Acids Res, vol. 51, no. 1 D, pp. D638–D646, Jan. 2023, doi: 10.1093/nar/gkac1000.
B. Franco-Juárez et al., “TFEB; Beyond Its Role as an Autophagy and Lysosomes Regulator,” Cells, vol. 11, no. 19. MDPI, Oct. 01, 2022. doi: 10.3390/cells11193153.
G. Napolitano and A. Ballabio, “TFEB at a glance,” J Cell Sci, vol. 129, no. 13, pp. 2475–2481, 2016, doi: 10.1242/jcs.146365.
D. Crighton et al., “DRAM, a p53-Induced Modulator of Autophagy, Is Critical for Apoptosis,” Cell, vol. 126, no. 1, pp. 121–134, Jul. 2006, doi: 10.1016/j.cell.2006.05.034.
M. A. Rahman et al., “p53 Modulation of Autophagy Signaling in Cancer Therapies: Perspectives Mechanism and Therapeutic Targets,” Frontiers in Cell and Developmental Biology, vol. 10. Frontiers Media S.A., Jan. 26, 2022. doi: 10.3389/fcell.2022.761080.
J. Pflaum, S. Schlosser, and M. Müller, “P53 family and cellular stress responses in cancer,” Front Oncol, vol. 4, no. OCT, 2014, doi: 10.3389/fonc.2014.00285.
M. Djavaheri-Mergny, M. Amelotti, J. Mathieu, F. Besançon, C. Bauvy, and P. Codogno, “Regulation of autophagy by NFκB transcription factor and reactives oxygen species,” Autophagy, vol. 3, no. 4, pp. 390–392, 2007, doi: 10.4161/auto.4248.
D. Verzella et al., “Life, death, and autophagy in cancer: NF-κB turns up everywhere,” Cell Death and Disease, vol. 11, no. 3. Springer Nature, Mar. 01, 2020. doi: 10.1038/s41419-020-2399-y.
Q. Li and I. M. Verma, “NF-κB regulation in the immune system,” Nature Reviews Immunology, vol. 2, no. 10. pp. 725–734, Oct. 2002. doi: 10.1038/nri910.
P. M. Nguyen, T. L. Putoczki, and M. Ernst, “STAT3-activating cytokines: A therapeutic opportunity for inflammatory bowel disease?,” Journal of Interferon and Cytokine Research, vol. 35, no. 5, pp. 340–350, May 2015, doi: 10.1089/jir.2014.0225.
S. W. Wang and Y. M. Sun, “The IL-6/JAK/STAT3 pathway: Potential therapeutic strategies in treating colorectal cancer (Review),” International Journal of Oncology, vol. 44, no. 4. pp. 1032–1040, Apr. 2014. doi: 10.3892/ijo.2014.2259.
J. Li, Z. Yin, B. Huang, K. Xu, and J. Su, “Stat3 Signaling Pathway: A Future Therapeutic Target for Bone-Related Diseases,” Frontiers in Pharmacology, vol. 13. Frontiers Media S.A., Apr. 25, 2022. doi: 10.3389/fphar.2022.897539.
L. You et al., “The role of STAT3 in autophagy,” Autophagy, vol. 11, no. 5, pp. 729–739, Jan. 2015, doi: 10.1080/15548627.2015.1017192.
L. A. Sheldon, “Inhibition of E2F1 activity and cell cycle progression by arsenic via retinoblastoma protein,” Cell Cycle, vol. 16, no. 21, pp. 2058–2072, Nov. 2017, doi: 10.1080/15384101.2017.1338221.
J. D. Graves, Y.-J. Lee, K. Liu, G. Li, F.-T. Lin, and W.-C. Lin, “E2F1 sumoylation as a protective cellular mechanism in oxidative stress response”, doi: 10.1073/pnas.1921554117/-/DCSupplemental.
S. Polager, M. Ofir, and D. Ginsberg, “E2F1 regulates autophagy and the transcription of autophagy genes,” Oncogene, vol. 27, no. 35, pp. 4860–4864, Aug. 2008, doi: 10.1038/onc.2008.117.
S. Polager and D. Ginsberg, “E2F - at the crossroads of life and death,” Trends in Cell Biology, vol. 18, no. 11. pp. 528–535, Nov. 2008. doi: 10.1016/j.tcb.2008.08.003.
W. A. Beltran et al., “CREB1/ATF1 activation in photoreceptor degeneration and protection,” Invest Ophthalmol Vis Sci, vol. 50, no. 11, pp. 5355–5363, Nov. 2009, doi: 10.1167/iovs.09-3741.
F. Yi et al., “Regulation of RB1CC1/FIP200 stability and autophagy function by CREBBP-mediated acetylation in an intrinsically disordered region,” Autophagy, vol. 19, no. 6, pp. 1662–1677, 2023, doi: 10.1080/15548627.2022.2148432.
S. Seok et al., “Transcriptional regulation of autophagy by an FXR-CREB axis,” Nature, vol. 516, no. 729, pp. 108–111, Dec. 2014, doi: 10.1038/nature13949.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Muna A. Abdal Rhida

This work is licensed under a Creative Commons Attribution 4.0 International License.